The present invention relates to compounds of formula (I):
or a pharmaceutically acceptable salt thereof, wherein A
1
, A
2
, L
1
and B are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A
4
hydrolase (LTA
4
H) and treating LTA
4
H related disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
本发明涉及式(I)的化合物或其药学上可接受的盐,其中A1、A2、L1和B的定义如本文所述。式(I)的化合物可用作
白三烯A4
水解酶(L
TA4H)的
抑制剂,并用于治疗L
TA4H相关疾病。本发明还涉及包括式(I)的化合物的药物组合物,使用这些化合物治疗各种疾病和疾病的方法,以及制备这些化合物的过程。